Literature DB >> 23781031

Secretion of ERP57 is important for extracellular matrix accumulation and progression of renal fibrosis, and is an early sign of disease onset.

Hassan Dihazi1, Gry Helene Dihazi, Asima Bibi, Marwa Eltoweissy, Claudia A Mueller, Abdul R Asif, Diana Rubel, Radovan Vasko, Gerhard A Mueller.   

Abstract

Renal fibrosis is characterized by excessive accumulation of extracellular matrix (ECM), which compromises organ function by replacing normal organ tissue. The molecular mechanisms leading to renal fibrosis are not fully understood. Here we demonstrated that TGFβ1, AGT or PDGF stimulation of renal cells resulted in endoplasmic reticulum (ER) stress followed by activation of the protective unfolded protein response pathway and a high secretory level of protein disulfide isomerase ERP57 (also known as PDIA3). The TGFβ1-induced impairment of ER function could be reversed by treatment with BMP7, suggesting a specific involvement in renal fibrosis. A clear correlation between the degree of fibrosis, ER stress and the level of ERP57 could be seen in fibrosis animal models and in biopsies of renal fibrosis patients. Protein interaction studies revealed that secreted ERP57 exhibits a strong interaction with ECM proteins. Knockdown of ERP57 or antibody-targeted inhibition of the secreted form significantly impaired the secretion and accumulation of ECM. Moreover, ERP57 was excreted in the early stages of chronic kidney disease, and its level in urine correlated with the degree of renal fibrosis, suggesting that the secretion of ERP57 represents one of the first signs of renal fibrosis onset and progression.

Entities:  

Keywords:  ECM; ER stress; ERP57; Renal fibrosis; UPR

Mesh:

Substances:

Year:  2013        PMID: 23781031     DOI: 10.1242/jcs.125088

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  30 in total

1.  Endoplasmic reticulum-resident protein 57 (ERp57) oxidatively inactivates human transglutaminase 2.

Authors:  Michael C Yi; Arek V Melkonian; James A Ousey; Chaitan Khosla
Journal:  J Biol Chem       Date:  2018-01-05       Impact factor: 5.157

Review 2.  Proteostasis in endoplasmic reticulum--new mechanisms in kidney disease.

Authors:  Reiko Inagi; Yu Ishimoto; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2014-04-22       Impact factor: 28.314

3.  DNA nanodevices map enzymatic activity in organelles.

Authors:  Krishna Dan; Aneesh T Veetil; Kasturi Chakraborty; Yamuna Krishnan
Journal:  Nat Nanotechnol       Date:  2019-02-11       Impact factor: 39.213

Review 4.  Chemistry and Enzymology of Disulfide Cross-Linking in Proteins.

Authors:  Deborah Fass; Colin Thorpe
Journal:  Chem Rev       Date:  2017-07-12       Impact factor: 60.622

Review 5.  Proteostasis control by the unfolded protein response.

Authors:  Claudio Hetz; Eric Chevet; Scott A Oakes
Journal:  Nat Cell Biol       Date:  2015-07       Impact factor: 28.824

Review 6.  Multifunctional molecule ERp57: From cancer to neurodegenerative diseases.

Authors:  Aubryanna Hettinghouse; Ronghan Liu; Chuan-Ju Liu
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

7.  Erratum: Proteostasis control by the unfolded protein response.

Authors:  Claudio Hetz; Eric Chevet; Scott A Oakes
Journal:  Nat Cell Biol       Date:  2015-08       Impact factor: 28.824

8.  Modifications of disulfide bonds in breast cancer cell migration and invasiveness.

Authors:  Marcin Popielarski; Halszka Ponamarczuk; Marta Stasiak; Cezary Watała; Maria Świątkowska
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

Review 9.  Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases.

Authors:  Andrey V Cybulsky
Journal:  Nat Rev Nephrol       Date:  2017-10-03       Impact factor: 28.314

10.  Urinary ERdj3 and mesencephalic astrocyte-derived neutrophic factor identify endoplasmic reticulum stress in glomerular disease.

Authors:  Nihad Tousson-Abouelazm; Joan Papillon; Julie Guillemette; Andrey V Cybulsky
Journal:  Lab Invest       Date:  2020-03-18       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.